Search
Discover new people, create new connections and make new friends
-
Please log in to like, share and comment!
-
Molecular Diagnostics Market Trends Highlight the Growing Importance of Oncology TestingThe global molecular diagnostics market is witnessing steady expansion as healthcare providers increasingly prioritize early disease detection, accurate diagnosis, and personalized treatment. The Molecular Diagnostics Market was valued at USD 18.8 billion in 2025 and is projected to increase from USD 19.4 billion in 2026 to USD 25.6 billion by 2033, registering a CAGR of 4.1% from 2026 to 2033....0 Comments 0 Shares 354 Views 0 Reviews
-
China Companion Diagnostics Oncology Market – Advancing Precision Cancer CareThe China Companion Diagnostics Oncology Market is an important area within precision medicine, oncology diagnostics, and targeted cancer treatment. Companion diagnostics help identify biomarkers that may indicate whether a patient is likely to benefit from a specific therapy. As cancer care becomes increasingly personalized, these diagnostic technologies can support more informed treatment...0 Comments 0 Shares 351 Views 0 Reviews
-
Hemato Oncology Testing Market Is Anticipated To Expand From $4.26 Billion In 2024 To $17.82 Billion By 2034, 2025–2035 | Roche Diagnostics | Abbott Laboratories | Siemens Healthineers | Danaher | Sysmex CorporationMarket Overview The global Hemato Oncology Testing Market is anticipated to expand from $4.26 billion in 2024 to $17.82 billion by 2034, growing at a CAGR of approximately 15.4% during the forecast period. The market encompasses diagnostic and prognostic solutions for hematological cancers, including leukemia, lymphoma, and myeloma. As cancer management increasingly moves toward precision...0 Comments 0 Shares 174 Views 0 Reviews
-
Oncology Based Molecular Diagnostics Market Outlook: Growing Adoption of Personalized Cancer TherapiesThe Oncology Based Molecular Diagnostics Market is rapidly evolving as precision medicine reshapes the global approach to cancer diagnosis and treatment. Molecular diagnostic technologies are enabling healthcare professionals to identify cancer-specific genetic alterations, detect tumors at earlier stages, and develop personalized treatment strategies based on individual patient...0 Comments 0 Shares 829 Views 0 Reviews
-
Oncology Diagnostics and Advanced Imaging Drive Global Market GrowthThe global diagnostic imaging services market is witnessing steady growth, supported by the increasing prevalence of chronic diseases, rising demand for early disease detection, and continuous advancements in medical imaging technologies. The market was valued at US$ 363.6 Bn in 2021 and is projected to expand at a CAGR of 4.1% from 2022 to 2031, reaching more than US$ 544.7 Bn by the end of...0 Comments 0 Shares 214 Views 0 Reviews
-
Why Is Precision Oncology Driving the North America Prostate Cancer Diagnostics Market?According to the latest report published by Data Bridge Market Research, the North America Prostate Cancer Diagnostics Market CAGR Value The North America prostate cancer diagnostics market size was valued at USD 2.53 billion in 2024 and is expected to reach USD 6.67 billion by 2032, at a CAGR of 12.90% during the forecast period Winning North America Prostate Cancer Diagnostics...0 Comments 0 Shares 500 Views 0 Reviews
-
Molecular Cytogenetics Market Demand for Advanced Chromosomal AnalysisThe global Molecular Cytogenetics Market was estimated at USD 2.40 billion in 2024 and is projected to reach USD 6.39 billion by 2033, expanding at a CAGR of 11.7% from 2025 to 2033. Market growth is driven by the increasing application of molecular cytogenetic techniques in clinical diagnostics and research, particularly for oncology, genetic disorders, and prenatal testing. The growing use of...0 Comments 0 Shares 361 Views 0 Reviews
-
How Is Genetic Risk Awareness Driving the North America Hereditary Cancer Testing Market?According to the latest report published by Data Bridge Market Research, the North America Hereditary Cancer Testing Market CAGR Value The North America hereditary cancer testing market size was valued at USD 3.39 billion in 2025 and is expected to reach USD 9.20 billion by 2033, at a CAGR of 13.3% during the forecast period Market research analysis and data in this North...0 Comments 0 Shares 984 Views 0 Reviews